Dominant expression of type III hyperlipoproteinemia. Pathophysiological insights derived from the structural and kinetic characteristics of ApoE-1 (Lys146-->Glu).

MLA

Mann, W. A., et al. “Dominant Expression of Type III Hyperlipoproteinemia. Pathophysiological Insights Derived from the Structural and Kinetic Characteristics of ApoE-1 (Lys146-->Glu).” The Journal of Clinical Investigation, vol. 96, no. 2, Aug. 1995, pp. 1100–07. EBSCOhost, https://doi.org/10.1172/JCI118096.

APA

Mann, W. A., Lohse, P., Gregg, R. E., Ronan, R., Hoeg, J. M., Zech, L. A., & Brewer, H. B., Jr. (1995). Dominant expression of type III hyperlipoproteinemia. Pathophysiological insights derived from the structural and kinetic characteristics of ApoE-1 (Lys146-->Glu). The Journal of Clinical Investigation, 96(2), 1100–1107. https://doi.org/10.1172/JCI118096

Chicago

Mann, W A, P Lohse, R E Gregg, R Ronan, J M Hoeg, L A Zech, and H B Brewer Jr. 1995. “Dominant Expression of Type III Hyperlipoproteinemia. Pathophysiological Insights Derived from the Structural and Kinetic Characteristics of ApoE-1 (Lys146-->Glu).” The Journal of Clinical Investigation 96 (2): 1100–1107. doi:10.1172/JCI118096.